Feasibility of a phase I personalized adoptive T-cell therapy in patients with relapsed/refractory solid tumors

JOURNAL FOR IMMUNOTHERAPY OF CANCER(2019)

Cited 1|Views22
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined